Literature DB >> 6160905

Effect of fibroblast, lymphoid, and myeloid interferons on human tumor colony formation in vitro.

E C Bradley, F W Ruscetti.   

Abstract

A variety of solid and hematological human tumors and normal human bone marrow specimens were assayed for colony formation in a short-term soft-agar culture system. The effect of human fibroblast, lymphoid, and myeloid interferons on inhibition of colony formation was assessed. The effect of interferon on colony formation formed a continuum from complete inhibition to stimulation of growth. Of 40 evaluable tumor specimens, 18 showed at least a 70% inhibition of colony formation in the presence of interferon, at concentrations of 1000 units/ml or less. Four specimens (acute myelogenous leukemia, osteogenic sarcoma, neuroblastoma, ovarian carcinoma) showed at least 3-fold stimulation of colony formation with interferon. Two of 12 normal bone marrow specimens grown with colony-stimulating, factor-conditioned media showed greater than 70% colony inhibition with interferon. A dose-response relationship was seen in all tumor specimens tested. While fibroblast interferon was the most active in this system, all interferons showed the same magnitude and direction of activity. Continuous exposure and 1-hr incubation of tumor cells with interferon were identical in terms of colony inhibition. These data support the ability of this assay system to select tumors responsive in vitro to interferon, suggest the optimal species and concentration for inhibition or stimulation of growth, and support a direct role of interferon in the regulation of cell growth independent of other immunoregulatory actions of interferon. Such information may prove useful for predicting response in vivo to interferon in Phase II trials.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6160905

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

Review 1.  Regulation of cell growth by interferon.

Authors:  M Shearer; J Taylor-Papadimitriou
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

2.  Antiproliferation and colony-forming inhibition activities of recombinant feline interferon (rFeIFN) on various cells in vitro.

Authors:  B P Priosoeryanto; S Tateyama; R Yamaguchi; K Uchida
Journal:  Can J Vet Res       Date:  1995-01       Impact factor: 1.310

Review 3.  The human tumor cloning assay in cancer drug development. A review.

Authors:  P Agre; T E Williams
Journal:  Invest New Drugs       Date:  1983       Impact factor: 3.850

4.  Sensitivity of fresh and cultured ovarian tumor cells to tumor necrosis factor, interferon-alpha 2, and OK-432.

Authors:  Y Nio; J Zighelboim; J S Berek; B Bonavida
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Effect of fibroblast interferon on colony tumor growth of miscellaneous solid human tumors.

Authors:  P Schlag; J Wolfrum; W Schreml; C Herfarth
Journal:  Klin Wochenschr       Date:  1982-12-01

6.  Antitumor activity of didemnin B in the human tumor stem cell assay.

Authors:  T L Jiang; R H Liu; S E Salmon
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

7.  Sectional analysis of tumor colony growth in the soft-agar assay: effects of oxygen.

Authors:  D Fan; S Fan; L R Morgan
Journal:  J Cancer Res Clin Oncol       Date:  1984       Impact factor: 4.553

8.  Characteristics of in vitro antiproliferation activity of human interferon-beta.

Authors:  T Kataoka; F Oh-hashi; Y Sakurai; N Ida
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

9.  Review of experience with interferon and drug sensitivity testing of ovarian carcinoma in semisolid agar culture.

Authors:  L B Epstein; S G Marcus
Journal:  Cancer Chemother Pharmacol       Date:  1981       Impact factor: 3.333

10.  Activity of human leukocyte interferon in a human tumor cloning system.

Authors:  D D Von Hoff; J Gutterman; B Portnoy; C A Coltman
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.